The above results, along with the previous report by Mosialou et al. 27, led us to hypothesize that celastrol-induced upregulation of LCN2 in the hypothalamus or circulation might mediate, or at least contribute to, the anorexigenic and anti-obesity effects of celastrol. Here, LCN2 is linked to obesity due to melanocortin 4 receptor deficiency.